| All patients (N = 172) N (%) | 2000-2005 (N = 47) N (%) | 2006-2011 (N = 125) N (%) |
Age at any metastases diagnosis | 52 (24 - 87) | 50 (27 -6 8) | 52 (24 - 87) |
Age at CNS metastases | 53 (24 - 87) | 51 (28 - 68) | 52 (24 - 87) |
Race/ethnicity n (%) White Hispanic AA Asian Missing |
80 (46.5) 44 (25.6) 12 (7) 28 (16.2) 8 (4.7) |
23 (48.9) 12 (25.5) 5 (10.6) 7 (15) |
54 (43.2) 35 (28) 7 (5.6) 21 (16.8) 8 (6.4) |
Marital Status Married Single Divorced/separated Widowed Unknown |
110 (63.9) 18 (10.5) 22 (12.8) 13 (7.6) 9 (5.2) |
42 (89.4) 4 (8.5) 1 (2.1) |
74 (59.2) 14 (11.2) 16 (12.8) 13 (10.4) 8 (6.4) |
CNS mets diagnosis De novo Progression Missing |
25 (14.5) 139 (80.8) 8 (4.7) |
4 (8.5) 43 (91.5) |
21 (16.8) 96 (76.8) 8 (16.4) |
Type Leptomeningeal Brain lesions |
17 (10) 155 (90) |
1 (2.1) 46 (97.9) |
16 (12.8) 109 (87.2) |
Extracranial metastases site Lung Liver Bone Skin Multiple sites |
3 (1.7) 2 (1.2) 26 (15.1) 2 (1.2) 139 (80.8) |
2 (4.2) 2 (4.2) 8 (17) 1 (2.1) 34 (72.5) |
1 (0.8)
18 (14.4) 1 (0.8) 105 (84) |
ER Negative Positive Unknown |
79 (45.9) 84 (48.8) 9 (5.3) |
20 (42.5) 20 (42.5) 7 (15) |
59 (47.2) 64 (51.2) 2 (1.6) |
PR Negative Positive Unknown |
103 (59.9) 59 (34.3) 10 (5.8) |
27 (57.4) 13 (27.7) 7 (14.9) |
76 (60.8) 46 (36.8) 3 (2.4) |
HER2 Negative Borderline Positive Unknown |
90 (52.3) 2 (1.2) 66 (38.4) 14 (8.1)
|
21 (44.7) 1 (2.1) 16 (34) 9 (19.2) |
69 (55.2) 1 (0.8) 50 (40) 5 (4) |
Histology Ductal Metaplastic Lobular Nos Inflammatory Mixed Missing |
114 (66.3) 1 (0.6) 8 (4.7) 12 (6.9) 18 (10.5) 9 (5.2) 10 (5.8) |
30 (63.8) 1 (2.1) 4 (8.6) 11 (23.4) 1 (2.1)
|
84 (67.2) 1 (0.8) 7 (5.6) 8 (6.4) 7 (5.6) 8 (6.4) 10 (8) |